Cyclosporine and Herbal Supplement Interactions

Cyclosporine (CyA) is a well-known immunosuppressant with a narrow therapeutic window. Its bioavailability is affected by many other traditional drugs and herbal extracts. Cytochrome P-450 isoenzymes CYP3A4 and CYP3A5 and protein P-glycoprotein (P-gp) are involved in CyA bioavailability. Interaction...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Colombo, L. Lunardon, G. Bellia
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2014/145325
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565167463858176
author D. Colombo
L. Lunardon
G. Bellia
author_facet D. Colombo
L. Lunardon
G. Bellia
author_sort D. Colombo
collection DOAJ
description Cyclosporine (CyA) is a well-known immunosuppressant with a narrow therapeutic window. Its bioavailability is affected by many other traditional drugs and herbal extracts. Cytochrome P-450 isoenzymes CYP3A4 and CYP3A5 and protein P-glycoprotein (P-gp) are involved in CyA bioavailability. Interactions of CyA with herbal extracts are not well known, but, given their increased concomitant use, it is important to know which extracts, many of which are commonly self-prescribed, can affect CyA blood concentrations. Decreased CyA blood concentration has been shown with St John’s wort in case reports and, in vivo animal studies, with ginger, liquorice, scutellariae radix, and quercetin. Increased CyA concentration has been reported in patients with grapefruit juice, chamomile, or berberine, and with cannabidiol or resveratrol in animal studies. Effects of Echinacea and Serenoa repens on CyA levels have not been shown consistently, but concomitant use should be avoided. Although findings from animal studies cannot be directly translated into humans, avoiding concomitant use of herbal extracts is prudent until human clinical studies have ruled out any possible interaction. Clinicians should interview their patients carefully about their use of herbal supplements before CyA administration, and those receiving CyA should be warned about possible interactions between herbal preparations and CyA.
format Article
id doaj-art-610784a906594c33800d47800922c4f7
institution Kabale University
issn 1687-8191
1687-8205
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-610784a906594c33800d47800922c4f72025-02-03T01:08:59ZengWileyJournal of Toxicology1687-81911687-82052014-01-01201410.1155/2014/145325145325Cyclosporine and Herbal Supplement InteractionsD. Colombo0L. Lunardon1G. Bellia2Novartis Farma S.p.A., Origgio, Varese, ItalyDepartment of Pathophysiology and Transplantation, University of Milan, I.R.C.C.S. Foundation, Cà Granda Ospedale Maggiore Policlinico, Milan, ItalyNovartis Farma S.p.A., Origgio, Varese, ItalyCyclosporine (CyA) is a well-known immunosuppressant with a narrow therapeutic window. Its bioavailability is affected by many other traditional drugs and herbal extracts. Cytochrome P-450 isoenzymes CYP3A4 and CYP3A5 and protein P-glycoprotein (P-gp) are involved in CyA bioavailability. Interactions of CyA with herbal extracts are not well known, but, given their increased concomitant use, it is important to know which extracts, many of which are commonly self-prescribed, can affect CyA blood concentrations. Decreased CyA blood concentration has been shown with St John’s wort in case reports and, in vivo animal studies, with ginger, liquorice, scutellariae radix, and quercetin. Increased CyA concentration has been reported in patients with grapefruit juice, chamomile, or berberine, and with cannabidiol or resveratrol in animal studies. Effects of Echinacea and Serenoa repens on CyA levels have not been shown consistently, but concomitant use should be avoided. Although findings from animal studies cannot be directly translated into humans, avoiding concomitant use of herbal extracts is prudent until human clinical studies have ruled out any possible interaction. Clinicians should interview their patients carefully about their use of herbal supplements before CyA administration, and those receiving CyA should be warned about possible interactions between herbal preparations and CyA.http://dx.doi.org/10.1155/2014/145325
spellingShingle D. Colombo
L. Lunardon
G. Bellia
Cyclosporine and Herbal Supplement Interactions
Journal of Toxicology
title Cyclosporine and Herbal Supplement Interactions
title_full Cyclosporine and Herbal Supplement Interactions
title_fullStr Cyclosporine and Herbal Supplement Interactions
title_full_unstemmed Cyclosporine and Herbal Supplement Interactions
title_short Cyclosporine and Herbal Supplement Interactions
title_sort cyclosporine and herbal supplement interactions
url http://dx.doi.org/10.1155/2014/145325
work_keys_str_mv AT dcolombo cyclosporineandherbalsupplementinteractions
AT llunardon cyclosporineandherbalsupplementinteractions
AT gbellia cyclosporineandherbalsupplementinteractions